Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect

April 29, 2016 – – LegalHerald.com reports on a verdict that was handed down last November for a lawsuit filed under case number 130401990. The complaint discussed antipsychotic drug Risperdal, and the drug’s possible connection to the development of gynecomastia among male patients. Gynecomastia is a condition which causes significant breast tissue development among men, therefore developing breasts that resemble those of a female. The claims have been upheld in the Court of Common Pleas in Philadelphia, Pennsylvania. It was reported, however, that a hearing on March 10th reduced the amount rewarded to the plaintiff from $1.75 million to $680,000.

Risperdal is a potent antipsychotic drug which is manufactured by Johnson & Johnson division Janssen Pharmaceuticals. It has been reported that the corporation is facing over 1,700 lawsuits referencing Risperdal at this time. The lawsuits have been transferred and consolidated to form a mass tort program in Philadelphia, Pennsylvania, which is now underway. The complaints consolidated in the mass tort have reportedly been filed on behalf of patients who have taken the drug and who have subsequently suffered from gynecomastia or other complications. Plaintiffs involved share common allegations that the side effects were caused by Risperdal, and believe that Johnson & Johnson could have intentionally hidden the potential of these side effects from patients and medical professionals. They also commonly claim that Johnson & Johnson was negligent in failing to properly warn doctors and consumers about the possibility of these negative side effects according to case number 100300296 of the Risperdal Litigation.

It has been indicated that current litigation has seen a total of four trials which surrounded allegations made against Risperdal and its possible link to gynecomastia. Plaintiffs in three out of these four trials have won, and have been awarded significant financial compensation. These plaintiffs have expressed that Risperdal side effects not only physically hurt them, but also caused them to suffer from severe emotional trauma as well. Plaintiffs who have developed severe gynecomastia note that surgery is their only option to attain a “normal” male body again.

The attorneys of Banville Law are currently working to help other patients who have used Risperdal and who believe that the drug has negatively impacted their health. They wish to ensure that these patients are provided an opportunity to fully investigate their legal rights in the matter, as they may be entitled to significant compensation. To better assist these patients, Banville Law is now offering free legal consultations for qualified parties. They also sponsor a website designed to keep the public informed of important information and updates surrounding the drug.

To request further Risperdal lawsuit information, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60009700